GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(4-methoxy-N(2-(3,4,5-trihydroxy-6- (HYDROXYMETHYL)TETRAHYDRO-2H-pyran-2-YLOXY)ETHYL)PHENYLSULFONAMIDO) acetamide

Analyse Crystal structure of the catalytic domain of human MMP12 complexed with the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3N2U
Type
protein
Length
158 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Macrophage metalloelastase
EC
3.4.24.65
UniProt
P39900
Ligands
D3X, CA, ZN
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMacrophage metalloelastase (EC 3.4.24.65)protein15826% helix, 17% strandP39900

Ligands and binding sites

  • D3X · N-hydroxy-2-{[(4-methoxyphenyl)sulfonyl](2-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}ethyl)amino}acetamide · ligand · chains A
  • CA · Calcium ion · metal · 3 copies · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11570.580.8224ZN, D3X

Compared structures

  • 3N2U · Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.